2018 WiT Life Sciences Ambassadors
Dr Carrie Hillyard, Chairman - Fitgenes
Dr Carrie Hillyard is currently an Angel investor and Chairman of Fitgenes and FizzioFit and Deputy Chairman of the Mater Medical Research Institute. She is also a member of the Entrepreneurs’ Program Committee of Innovation and Science Australia and a director of the Academy of Technological Sciences and Engineering (ATSE). Previously, she was a co-founder of venture fund, CM Capital Investments, a director of several of its investee companies and led its Life Sciences group for over 10 years. She has commercialised products from laboratory bench to market and is an inventor of a number of patented technologies. Her previous experience was in medical and diagnostics research in the UK and Australia. Carrie has also mentored entrepreneurs, assisted with commercialisation and licensing and served on a number of government, public and private company boards, including membership of the former Industry Research and Development Board and ANSTO. Dr Hillyard has a PhD from London University and is a Fellow of ATSE and of the Australian Institute of Company Directors. She is a recipient of a Centenary medal, the inaugural Women in Technology Biotechnology Star award and the AusBiotech Excellence award for her contributions to the biotechnology industry.
Prof. Colleen Nelson, Chair Prostate Cancer, QUT; Director Australian Prostate Cancer Research Centre, QUT ihbi
Professor Nelson is recognised as a leader in programmatic translational prostate cancer research and for strategic development of international collaborative research Centres and networks accelerate the translation of scientific discoveries into clinical and commercial applications. She founded and directs the Australian Prostate Cancer Research Centre- Queensland, where she leads 80 transdisciplinary Faculty and researchers. Prof Nelson has made significant contributions to prostate cancer translational research, specifically in characterising androgen action, identifying novel potential therapeutic targets; their validation and translation into the clinic. Her greatest impact has been on androgen targeted therapies and uncovering mechanisms underlying castrate resistant prostate cancer. Over her career she has been awarded more than $214M in international funding, and has organised, chaired, and presented at numerous international meetings and holds executive positions on prostate cancer advisory boards and committees. Prof Nelson has 21 international patents, 7 book chapters, 150 peer-reviewed publications, >200 conference abstracts, >7,000 citations and an H Index of 45 derived from > 20 years of prostate cancer expertise. She has been an invited speaker at 118 national and international conferences including the American Society of Clinical Oncology, Endocrine Society, European Association of Urology, ASCO-Genitourinary Cancers Symposium, American Society of Andrology, UK Prostate Cancer Forum, Prostate Cancer Foundation, Australian Society of Medical Research, Pfizer Oncology Forum, Discovery Science & Biotechnology Australia, World Microarray Congress and World Prostate Cancer Congress.
Prof. Neena Mitter, Theme Leader Agricultural Nanotechnology - The University of Queensland
2018 WiT ICT Ambassador
Bernadette Hyland, Founder
and CEO of 3 Round Stones Inc.
|Pamela Russell||Heidi Uytendaal||Helen Murray|
|Elizabeth Harper||Selena Bartlett||Maree Adshead||Judith Clements|
|Dimity Dornan ||Richi Nayak |